Gut Microbiome–Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort

por Reichard, Chad A., Naelitz, Bryan D., Wang, Zeneng, Jia, Xun, Li, Jianbo, Stampfer, Meir J., Klein, Eric A., Hazen, Stanley L., Sharifi, Nima
Publicado 2022

MON-140 Prolactin to Testosterone Ratio Reduces Pituitary Magnetic Resonance Imaging Expenditures for Hypogonadal Men with Mild Hyperprolactinemia

por Naelitz, Bryan D, Farber, Nicholas J, Shah, Anup B, Bryk, Darren J, Parekh, Neel V, Shoskes, Daniel A, Hatipoglu, Betul A, Vij, Sarah C
Publicado 2020

MON-275 Prolactin to Testosterone Ratio Predicts Pituitary Pathology in Hypogonadal Men with Mild Hyperprolactinemia

por Naelitz, Bryan D, Shah, Anup B, Bryk, Darren J, Farber, Nicholas J, Parekh, Neel V, Shoskes, Daniel A, Hatipoglu, Betul A, Vij, Sarah C
Publicado 2020